title: Symptomatic therapy in multiple sclerosis: Big pharma should do more--commentary.
authors.affiliation: St Vincent's University Hospital, Ireland mhutchin2@mac.com.
authors.forename: Michael
authors.initials: M
authors.lastname: Hutchinson
mesh_terms: D004345:Drug Industry / Q000639:trends*; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy*